Since the FOXC2 is a key regulator that activates epithelial-mesenchymal transition (EMT) and metastasis, suppression of FOXC2 by resveratrol-mediated regulation of the miR-520h-PP2A/C axis induces mesenchymal-epithelial transition (MET) and exerts anticancer effects in lung cancer cells. The gene discussed is FOXC2; the disease is lung cancer.